Skip to Content
Søg Menu

Biomarkers for Early Alzheimer’s Disease

Neurologist Kristian Steen Frederiksen from Rigshospitalet discusses biomarkers for early Alzheimer’s disease, highlighting the importance of a biomarker-based diagnosis.
Kristian Steen Frederiksen

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Ny Alzheimers-behandling reducerer aflejringer – men ikke uden etiske dilemmaer 

/ Steen Gregers Hasselbalch / Jan Andreasen
Alzheimer
Frederikke Kragh Clemmensen

Blodbaserede biomarkører kan forudsige udvikling af Alzheimers sygdom

/ Frederikke Kragh Clemmensen
AlzheimerDNS25 Play the Video 01:36

Positive Clinical Effects in the Early Stages of Alzheimer’s Disease: A Focus on Disease-Modifying Therapies

/ BestPractice Nordic
AlzheimerEAN24

Den første indikator på tidlig Alzheimers kan være andet end begyndende dårlig hukommelse

/ Line Damsgaard
Alzheimer
Anne Koivisto

The Risk of Alzheimer’s Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

/ Anne Koivisto
AlzheimerNeurologipäivät24 Play the Video 02:35
Eino Solje

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer’s and Dementia

/ Eino Solje
AlzheimerNeurologipäivät24 Play the Video 1:25

New Biomarkers May Be Key to Earlier Alzheimer’s Diagnosis and Treatment

/ Janet Jianying Zhang / He-Ling Wang / Anne-Brita Knapskog / Geir Selbæk / Evandro Fei Fang
Alzheimer
Kristian Steen Frederiksen

Nordic Evening EAN 2024: Highlights on Alzheimer’s

/ Kristian Steen Frederiksen
AlzheimerEAN24 Play the Video 4:05
Kristian Steen Frederiksen

New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

/ Kristian Steen Frederiksen
AlzheimerEAN24 Play the Video 4:28
Back to top